BRIDGED PIPERIDINE DERIVATIVES AS MELANOCORTIN RECEPTOR AGONISTS

Certain novel bridged piperidine derivatives of formula (I): (see formula I) are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and...

Full description

Saved in:
Bibliographic Details
Main Authors YE, ZHIXIONG, SEBHAT, IYASSU K, GUO, LIANGQIN, NARGUND, RAVI P, BARAKAT, KHALED J
Format Patent
LanguageEnglish
French
Published 04.05.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Certain novel bridged piperidine derivatives of formula (I): (see formula I) are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of (MC-4R), such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
Bibliography:Application Number: CA20022453609